US2021106547A1
|
|
Managing Cardiovascular Conditions Associated with Kidney Disease
|
US2021093597A1
|
|
KRAS Agonists, Pharmaceutical Compositions, and Uses in Managing Cancer
|
WO2021062012A1
|
|
Use of klk10 and engineered derivatizations thereof
|
WO2021050721A1
|
|
Quinoline derivatives and uses in managing cancer
|
WO2021046342A1
|
|
Systems and methods for detecting sleep activity
|
US2021059683A1
|
|
Methods and Devices Configured to Prevent Aspiration
|
WO2021041891A1
|
|
Use of deoxycholic acid, derivatives, or salts thereof in managing bacterial infections and compositions related thereto
|
WO2021035214A1
|
|
Nucleoside prodrugs and uses related thereto
|
US2021041853A1
|
|
Systems, Devices, and Methods for Generating a Model of a Vascular Network, and for Analyzing and/or Treatment Planning Related to Thereof
|
US2021022726A1
|
|
Orthopedic Fixation Devices and Methods
|
WO2021055081A1
|
|
Endothelial and smooth muscle like tissue produced from urine cells and uses related thereto
|
WO2021007512A1
|
|
Platinum-based chemotherapy, mast binding agents, glucocorticoid receptor (gr) binding agents, and/or hsp90 binding agents for uses in treating cancer
|
WO2021007499A1
|
|
Combination therapies for managing cancer
|
WO2021007312A1
|
|
Systems and methods for determining antimicrobial resistance of a sample using surface topography determined from optical imaging data
|
WO2021040880A1
|
|
Systems and methods for correcting intravoxel and/or voxel inhomogeneity and/or standardizing steady-state signal
|
US2021024985A1
|
|
Devices and Methods Useful for Imaging Transient and Rare Mechanical Events in Cells
|
WO2020247914A1
|
|
Kras g12v mutant binds to jak1, inhibitors, pharmaceutical compositions, and methods related thereto
|
WO2020247598A1
|
|
Photolysis to unlock caged protein therapeutics
|
WO2020247665A1
|
|
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
WO2020242933A1
|
|
Asparagine endopeptidase (aep) inhibitors, compositions, and uses related thereto
|